Evidence map›Paper›PMID 38071719›Full record

ArticleAnnals of surgical oncology2024

Thermal Ablation Versus Partial Nephrectomy for cT1 Renal Mass in a Solitary Kidney: A Matched Cohort Comparative Analysis.

Worapat Attawettayanon, Akira Kazama, Yosuke Yasuda, J J H Zhang, Snehi Shah, Nityam Rathi, Carlos Munoz-Lopez, Kieran Lewis, Jianbo Li, Alp T Beksac and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Worapat Attawettayanon *Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Akira Kazama *Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Yosuke YasudaGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
J J H ZhangGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Snehi ShahGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Nityam RathiGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Carlos Munoz-LopezGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Kieran LewisGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Jianbo LiDepartment of Quantitative Health Sciences, Lerner Research Institute, Cleveland, OH, USA.
Alp T BeksacGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Rebecca A CampbellGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Jihad KaoukGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Georges-Pascal HaberGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Christopher WeightGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Charles MartinDepartment of Interventional Radiology, Cleveland Clinic, Cleveland, OH, USA.
Steven C CampbellGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. campbes3@ccf.org.
Cleveland Clinic · USNiigata University · JPUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNephron-sparing approaches are preferred for renal mass in a solitary kidney (RMSK), with partial nephrectomy (PN) generally prioritized. Thermal ablation (TA) also is an option for small renal masses in this setting; however, comparative functional/survival outcomes are not well-defined.

methodsA retrospective study of 504 patients (1975-2022) with cT1 RMSK managed with PN (n = 409)/TA (n = 95) with necessary data for analysis was performed. Propensity score was used for matching patients, including age, preoperative glomerular filtration rate (GFR), tumor diameter, R.E.N.A.L. ((R)adius (tumor size as maximal diameter), (E)xophytic/endophytic properties of tumor, (N)earness of tumor deepest portion to collecting system or sinus, (A)nterior (a)/posterior (p) descriptor, and (L)ocation relative to polar lines), and comorbidities. Functional outcomes were compared, and Kaplan-Meier was used to analyze survival.

resultsThe matched cohort included 132 patients (TA = 66/PN = 66), with median tumor diameter of 2.4 cm, R.E.N.A.L. of 6, and preoperative GFR of 52 ml/min/1.73 m

conclusionsFunctional outcomes for TA for RMSK were improved compared with PN. Local recurrence was more common after TA and often was associated with the laparoscopic approach, multifocality, and large tumor size. Improved patient selection and greater experience with TA should improve outcomes. Salvage of LR was not always possible. Partial nephrectomy remains the reference standard for RMSK.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsSolitary KidneyHumansNephrectomyRetrospective StudiesTreatment OutcomeNephron sparing surgeryPartial nephrectomyRenal cell carcinomaSolitary kidneyThermal ablation

Identifiers

PMID38071719
OpenAlexW4389521353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.